ADDvise Group (OM:ADDV A) - Stock Price, News & Analysis

Resumen acción ADDV A

ADDvise Group AB (publ) suministra equipos a centros sanitarios y de investigación de los sectores público y privado de Suecia, el resto de Europa, Norteamérica, África y Asia.

Acerca de la empresa

ADDV A fundamental analysis
Snowflake Score
Valuation	5/6
Future Growth	4/6
Past Performance	2/6
Financial Health	2/6
Dividends	0/6

Recompensas

Cotiza un 91.9% por debajo de nuestra estimación de su valor razonable

Se prevé un crecimiento anual de los beneficios de 19.03%

Los beneficios aumentaron un 27.6% el año pasado

Trading a buen valor en comparación con empresas similares e industria

Análisis de riesgos

Los pagos de intereses no están bien cubiertos por los beneficios

Los accionistas han sido diluidos en el último año

Grandes partidas extraordinarias que afectan a los resultados financieros

Competidores de ADDvise Group AB (publ)

Stille

OM:STIL

kr1.7b

C-Rad

OM:CRAD B

kr1.3b

Paxman

OM:PAX

kr718.7m

Surgical Science Sweden

OM:SUS

kr7.7b

Historial de precios y rendimiento

Summary of all time highs, changes and price drops for ADDvise Group
Historical stock prices
Current Share Price	kr12.90
52 Week High	kr25.60
52 Week Low	kr9.72
Beta	0.40
1 Month Change	-2.27%
3 Month Change	-16.23%
1 Year Change	-6.86%
3 Year Change	300.62%
5 Year Change	538.61%
Change since IPO	-50.86%

Noticias y actualizaciones recientes

ADDvise Group AB (publ)'s (STO:ADDV A) 28% Cheaper Price Remains In Tune With Earnings

Feb 23

Recent updates

ADDvise Group AB (publ)'s (STO:ADDV A) 28% Cheaper Price Remains In Tune With Earnings

Feb 23

Need To Know: Analysts Are Much More Bullish On ADDvise Group AB (publ) (STO:ADDV A) Revenues

Nov 08

ADDvise Group (STO:ADDV A) Ticks All The Boxes When It Comes To Earnings Growth

Oct 21

Does ADDvise Group (STO:ADDV A) Have A Healthy Balance Sheet?

Sep 25

ADDvise Group AB (publ) Just Beat EPS By 69%: Here's What Analysts Think Will Happen Next

Jul 26

News Flash: Analysts Just Made A Meaningful Upgrade To Their ADDvise Group AB (publ) (STO:ADDV A) Forecasts

Mar 15

Is ADDvise Group (STO:ADDV A) A Risky Investment?

Jan 24

Is ADDvise Group (STO:ADDV A) A Risky Investment?

Sep 02

What Does ADDvise Group AB (publ)'s (STO:ADDV A) Share Price Indicate?

Aug 12

Rentabilidad de los accionistas

	ADDV A	SE Medical Equipment	Mercado SE
7D	-3.7%	-0.2%	-1.6%
1Y	-6.9%	-7.7%	9.7%

Rentabilidad frente al sector: ADDV A igualó al sector Swedish Medical Equipment , que obtuvo un rendimiento del -7.2% el año pasado.

Rentabilidad vs. Mercado: ADDV A obtuvo unos resultados inferiores a los del mercado Swedish, que fue del 17.1% el año pasado.

Volatilidad de los precios

Is ADDV A's price volatile compared to industry and market?
ADDV A volatility
ADDV A Average Weekly Movement	7.0%
Medical Equipment Industry Average Movement	7.6%
Market Average Movement	6.1%
10% most volatile stocks in SE Market	13.5%
10% least volatile stocks in SE Market	3.5%

Precio estable de las acciones: ADDV Aha sido volátil en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de ADDV A (9%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

Fundada	Empleados	CEO	Página web
1989	624	Rikard Akhtarzand	www.addvisegroup.se

ADDvise Group AB (publ) suministra equipos a centros sanitarios y de investigación de los sectores público y privado de Suecia, el resto de Europa, Norteamérica, África y Asia. La unidad de negocio Lab suministra mobiliario de laboratorio, ventilación, salas climatizadas/limpias y equipos de laboratorio a las industrias farmacéutica y de investigación en ciencias de la vida. También se dedica al diseño, construcción e instalación de salas blancas.

Resumen de fundamentos de ADDvise Group AB (publ)

¿Cómo se comparan los beneficios e ingresos de ADDvise Group con su capitalización de mercado?
Estadísticas fundamentales de ADDV A
Capitalización bursátil	kr1.62b
Beneficios(TTM)	kr103.50m
Ingresos (TTM)	kr1.38b

24.8x

Ratio precio-beneficio (PE)

1.9x

Ratio precio-ventas (PS)

¿Está ADDV A sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de ADDV A
Ingresos	kr1.38b
Coste de los ingresos	kr479.50m
Beneficio bruto	kr899.30m
Otros gastos	kr795.80m
Beneficios	kr103.50m

Últimos beneficios comunicados

Dec 31, 2023

Próxima fecha de beneficios

Apr 18, 2024

Beneficios por acción (BPA)	0.52
Margen bruto	65.22%
Margen de beneficio neto	7.51%
Ratio deuda/patrimonio	248.3%

¿Cómo se ha desempeñado ADDV A a largo plazo?

Ver rendimiento histórico y comparativa

Resumen acción ADDV A

Recompensas

Análisis de riesgos

Competidores de ADDvise Group AB (publ)

OM:STIL

kr1.7b

OM:CRAD B

kr1.3b

OM:PAX

kr718.7m

OM:SUS

kr7.7b

Historial de precios y rendimiento

Noticias y actualizaciones recientes

ADDvise Group AB (publ) has filed a Follow-on Equity Offering in the amount of SEK 100 million.

Addvise Group AB (Publ) Announces Erland Pontusson Decline Re-Election from the Board

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: kr0.56 (vs kr0.46 in FY 2022)

ADDvise Group AB (publ)'s (STO:ADDV A) 28% Cheaper Price Remains In Tune With Earnings

Investor sentiment deteriorates as stock falls 18%

Recent updates

ADDvise Group AB (publ) has filed a Follow-on Equity Offering in the amount of SEK 100 million.

Addvise Group AB (Publ) Announces Erland Pontusson Decline Re-Election from the Board

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: kr0.56 (vs kr0.46 in FY 2022)

ADDvise Group AB (publ)'s (STO:ADDV A) 28% Cheaper Price Remains In Tune With Earnings

Investor sentiment deteriorates as stock falls 18%

Investor sentiment improves as stock rises 17%

Investor sentiment improves as stock rises 20%

ADDvise Group AB (publ) (OM:ADDV A) acquired Axelerist, Inc. for $29.4 million.

With EPS Growth And More, ADDvise Group (STO:ADDV A) Makes An Interesting Case

Consensus EPS estimates fall by 19%, revenue upgraded

Third quarter 2023 earnings released

ADDvise Group AB (publ) to Report First Half, 2024 Results on Jul 18, 2024

New minor risk - Share price stability

Investor sentiment improves as stock rises 18%

ADDvise Group AB (publ) (OM : ADDV A) completed the acquisition of Diabetic Supply Inc.

ADDvise Group AB (publ) Announces Management Changes

Addvise Group AB (Publ) Appoints Oliver Humlen as Member of the Executive Management Team

ADDvise Group AB (publ) Provides Earnings Guidance for the Year 2023

New major risk - Financial position

Second quarter 2023 earnings released

Investor sentiment improves as stock rises 19%

ADDvise Group AB (publ) (OM:ADDV A) signed a Letter of Intent to acquire Innovative Endoscopy Components, L.L.C. for $11.75? million.

Here's Why ADDvise Group (STO:ADDV A) Has Caught The Eye Of Investors

Investor sentiment deteriorates as stock falls 26%

Now 32% undervalued

Investor sentiment improves as stock rises 20%

Here's Why ADDvise Group (STO:ADDV A) Can Manage Its Debt Responsibly

ADDvise Group AB (publ) (OM:ADDV A) has signed a Letter of Intent to acquire Kolplast CI S.A. for approximately BRL 210 million.

Investor sentiment improves as stock rises 17%

Is ADDvise Group AB (publ) (STO:ADDV A) Trading At A 43% Discount?

First quarter 2023 earnings released

Investor sentiment improves as stock rises 17%

Full year 2022 earnings released: EPS: kr0.45 (vs kr0.02 in FY 2021)

ADDvise Group AB (publ) (OM:ADDV A) signed a letter of intent to acquire X-Ray Cassette Repair Company, Inc. for approximately $15 million.

Investor sentiment improves as stock rises 18%

Is ADDvise Group (STO:ADDV A) A Risky Investment?

ADDvise Group Appoints Fredrik Mella as Senior Vice President Alongside His Current Role as Chief Operating Officer

High number of new and inexperienced directors

Need To Know: Analysts Are Much More Bullish On ADDvise Group AB (publ) (STO:ADDV A) Revenues

ADDvise Group AB (publ) to Report Fiscal Year 2022 Final Results on Apr 05, 2023

Second quarter 2022 earnings released: EPS: kr0.11 (vs kr0.001 in 2Q 2021)

Investor sentiment improved over the past week

ADDvise Group (STO:ADDV A) Ticks All The Boxes When It Comes To Earnings Growth

ADDvise Group AB (publ), Annual General Meeting, May 05, 2023

Does ADDvise Group (STO:ADDV A) Have A Healthy Balance Sheet?

ADDvise Group AB (publ) (OM:ADDV A) entered into a letter of intent to acquire Clinichain Holding B.V. for €33.80 million.

ADDvise Group AB (publ) Just Beat EPS By 69%: Here's What Analysts Think Will Happen Next

Second quarter 2022 earnings: Revenues exceed analyst expectations

Price target increased to kr9.25

High number of new and inexperienced directors

ADDvise Group AB (publ) (OM:ADDV A) completed the acquisition of Seebreath AB from the shareholders.

ADDvise Group AB (publ) Announces Executive Changes

First quarter 2022 earnings: EPS misses analyst expectations

First quarter 2022 earnings: Revenues in line with analyst expectations

ADDvise Group AB (publ) (OM:ADDV A) completed the acquisition of Surplus Diabetic, Inc for $19.5 million.

News Flash: Analysts Just Made A Meaningful Upgrade To Their ADDvise Group AB (publ) (STO:ADDV A) Forecasts

Consensus revenue estimates increase by 18%

Full year 2021 earnings: EPS misses analyst expectations